News & Events

May 4, 2006

N-Glycanase^® Patent Maintained in Europe

European Patent No. 0 472 651 in the name of Genzyme Corporation with opposition by Roche Diagnostics GmbH was maintained in oral proceedings before the Technical Board of Appeals.

See here a copy of the preliminary minutes.

See the full minutes.

N-Glycanase^® is a registered trademark of Genzyme Corporation, Boston, MA, USA. Recombinant PNGase F is covered by US Patent No 5,238,821 and EP Patent No 0472651 B1, which are exclusively licensed for manufacture by ProZyme, Inc.